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1. Introduction 
The primary structure of bovine growth hormone 
(BGH) has been studied by several groups over the last 
few years [l-5] . The hormone possesses a single po- 
lypeptide chain containing 4 methionine residues, the 
approximate positions of which are indicated in fig. 1. 
This paper describes studies on the reaction of these 
residues with iodoacetic acid. The investigation was 
designed to determine the importance of methionine 
for the biological activity of the hormone and to assess 
the relative reactivities of the 4 residues of this amino 
acid. Carboxymethylation was carried out at pH 3.5, 
at which pH only methionine residues should react [6] ; 
they are converted to S-carboxymethylmethionine: 
CH 
I 3 
+s - CH, - COO- 
ICH 
I 2 
CH 
I 2 
. . . .HN - CH - CO.. . . 
The results show that carboxymethylation of all the 
methionine residues in BGH leads to almost complete 
loss of growth promoting activity. The 4 residues differ 
considerably in their reactivities, residue II (fig. 1) being 
least readily carboxymethylated. 
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2. Experimental 
2.1. Materials 
BGH was prepared by the method of Wallis and 
Dixon [7] . 2-14C-iodoacetic acid (specific activity 7 
mCi/mmole) was obtained from the Radiochemical 
Centre (Amersham, Bucks). Trypsin (TPCK-treated) 
and a-chymotrypsin (3 x crystallized) were obtained 
from Worthington Biochemical Corporation. 
2.2. Preparation and characterization of carboxymethyl- 
bovine growth hormone 
BGH was dissolved in formate/formic acid buffer, 
containing urea (0.2 M sodium formate, 8 M urea, pH 
3.5) to give 8 mg protein/ml, and recrystallized iodo- 
acetic acid (100 mole of protein; a 25fold molar ex- 
cess over methionine residues) was added and dissolved. 
The mixture was incubated at 37” for 24 hr, and then 
dialysed against distilled water and freeze dried. As a 
control, a second sample of BGH was treated in the 
same way, but without the addition of iodoacetic acid. 
The degree of carboxymethylation of methionine 
cannot be easily assessed by acid hydrolysis and amino 
acid analysis, because S-carboxymethylmethionine is 
readily degraded [6] . The protein was therefore sub- 
jected to performic acid oxidation [8] and then hydro- 
lysed (0.68 mg protein, 0.2 ml 6 N HCI, 1 IO”, 24 hr) 
and analysed on a Locarte amino acid analyser. Com- 
plete absence of methionine sulphone from the hydro- 
lysate indicated that all the methionine of the original 
BGH had been carboxymethylated [6,9] . 
The growth promoting activity of carboxymethylated 
BGH was assayed in pituitary dwarf mice (Snell’s strain) 
[ 10, 1 I] , and compared with that of the control BGH 
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Fig. 1. Amino acid sequences around the 4 methionine residues 
of bovine growth hormone. The numbers in parentheses give 
the approximate number of residues in the regions between the 
sequences hown. Double-headed arrows below the sequence 
show the peptides isolated in the present work. The N-terminal 
Ala residue is in parentheses because it is missing in about half 
the molecules [4]. The Fire is based on the data of [l-5] and 
on the present studies. 
sample which had been treated with urea but not iodo- 
acetic acid. 
2.3. Preparation of 14C-labelled carboxymethyl-bovine 
growth hormone; reactivity of methionine residues 
BGH was dissolved in the same formate/formic acid 
buffer as before, at a concentration of 8 mg/ml. In 
studies involving the effect of a denaturing agent on the 
reactivity of the methionine residues, 8 M urea was in- 
cluded in the reaction mixture, otherwise it was omitted. 
Sufficient 2-14C-iodoacetic acid was added to give a 
2-fold molar excess of iodoacetic acid over protein (0.5 
I.tmole of iodoacetic acid/pmole of methionine). The 
mixture was incubated for 24 hr at 37”, and then excess 
unlabelled (recrystallized) iodoacetic acid was added to 
give 100 Cunoles/floie of protein (a 25fold molar ex- 
cess over methionine). Urea, if not already present, was 
added to give a final concentration of about 8 M. The 
mixture was incubated for a further 24 hr at 37”, and 
then dialysed against distilled water and freeze dried. 
The conditions used for the second incubation give com- 
plete carboxymethylation of the methionine residues 
in BGH (see sect. 2.2). 
14C-carboxymethyl-BGH was digested with trypsin 
and chymotrypsin. 4 mg of the modified hormone 
were suspended in 1 ml N-ethylmorpholine/acetic acid 
buffer (0.2 M in N-ethylmorpholine, pH 8.5) and di- 
gested with 80 fig of TPCK-treated trypsin (3 hr, 37”), 
and then 80 E.cg of chymotrypsin (3 hr, 37”). The digest 
was freeze dried. 
Peptides were separated on a peptide map (2 mg of 
digest/map) by 2-dimensional high voltage paper elec- 
trophoresis [ 121 (first dimension: pH 6.5, 10% pyridine, 
0.3% acetic acid. 89.7% water; 55 min, 2.5 kV; second 
dimension: pH 2, 8% acetic acid, 2% formic acid, 90% 
water, 70 min, 2.5 kV). The position of radioactive 
peptides was detected by autoradiography (Kodak 
‘Kodirex’ X-ray film; 4 days). The radioactive peptide 
spots that were positively or negatively charged at 
pH 6.5 were cut out and eluted with pH 2 buffer. The 
region of the peptide map containing peptides neutral 
at pH 6.5 (within which separation was incomplete) 
was cut out, sewn onto another piece of chromato- 
graphy paper and chromatographed in n-butanol/acetic 
acid/water/pyridine (75/15/60/50, by vol). This gave 
a map of the neutral peptides. Again, radioactive pep- 
tides were detected by autoradiography, and eluted 
with pH 2 electrophoresis buffer. 
Samples of the radioactive peptides (4) were taken 
for hydrolysis (6 N HCl, 1 lo’, 24 hr, sealed evacuated 
tubes, plus a trace of phenol) and amino acid analysis 
on a Locarte amino acid analyser. Samples were also 
taken for scintillation counting (&J ) - these were dried 
onto glass fibre discs and counted in a Beckman scintil- 
lation counter in toluene containing 0.35% 2,5-diphenyl- 
oxazole, and 0.005% 1,4-bis-(5.phenyloxazol-2-yl) 
benzene dimethyl ester. 
From the information available about the amino 
acid sequence of BGH [l-5] and the amino acid com- 
positions of the peptides isolated, it was possible to 
assign each radioactive peptide to a sequence around a 
methionine residue. Further sequence studies have con- 
firmed these assignments. No evidence was obtained 
for modification of any residue other than methionine. 
The specific activity (dpm/nmole) of each peptide and 
hence each methionine residue could then be determined. 
These specific activities reflect the relative reactivities 
of the different methionine residues, since labelling 
took place when these residues were competing for a 
rather small amount of iodoacetic acid during the first 
stage of the carboxymethylation procedure. 
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Table 1 
Growth promoting activity of carboxymethyl-bovine growth hormone in dwarf mice. 
Sample Number of animals Weight gain (g) (+ S.E.M.) 
Assay I 1. saline controls 5 + 0.41 (f 0.36) 
2. 2 pg BGH/day 6 + 1.51* (k 0.31) 
3. lO~gBGH/day 5 + 2.90** (f 0.40) 
4. 10 pg urea treated BGH/day 4 + 2.62** (f 0.20) 
5. 20 I.cg carboxymethyl- 
BGH/day 6 + 0.14 (+ 0.25) 
Assay II 6. saline controls 6 + 1.01 (+ 0.17) 
I. 2 pg BGH/day 6 t 1.85** (+ 0.15) 
8.5 pg BGHjday 6 + 2.73*** (k 0.28) 
9.40 pg carboxymethyl- 
BGH/day 6 + 1.14 (+- 0.21) 
10.5 pg BGH + 40 pg 
carboxymethyl-BGH/day 6 t 3.40*** (i 0.36) 
The weight gain shown was the mean increase in weight for each group of mice after 21 (Assay I) or 22 (Assay II) daily injections 
of the test solution indicated. The volume injected was 0.1 ml/day in every case, and all the samples were dissolved in 0.9% NaCl 
and adjusted to pH 7 - 9. For the difference between samples and the appropriate controls: * p < 0.05, *-*-p < 0.01, *** p < 0.001. 
The differences between 1 and 5, 3 and 4,6 and 9, and 8 and 10 are not significant. 
3. Results 
3.1. Characterization and biological activity of carboxy- 
methyl-bovine growth hormone 
Amino acid analysis of carboxymethyl-BGH prepared 
as described in sect. 2.2 showed that the composition 
of the carboxymethylated, performic oxidized hor- 
mone was identical to that of performic oxidized BGH 
except for the complete absence of methionine sulphone. 
The latter was replaced by the breakdown products of 
S-carboxymethylmethionine (S-carboxymethylhomo- 
cysteine, methionine, homoserine and homoserine 
lactone [6] ). The result indicates that all the methio- 
nine groups of the protein had been carboxymethyl- 
ated, and that no other residues had been modified 
(though modification of other residues cannot be ex- 
cluded completely since acid hydrolysis might remove 
the modifying group). 
The growth promoting activity of carboxymethyl- 
BGH in dwarf mice is shown in table 1. BGH treated 
with urea (but not iodoacetic acid) under the condi- 
tions used for carboxymethylation had growth pro- 
moting activity which was not significantly different 
from that of the untreated hormone (Assay I). Car- 
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boxymethyl-BGH however showed no growth promot- 
ing activity at a dose of 20 or 40 c(g per day, though 
2 pg per day of untreated hormone was active. Clearly 
the activity of the carboxymethylated hormone is less 
than 5% of that of untreated hormone. Since the latter 
had a potency of about 2.0 I.U. per mg, the potency of 
carboxymethyl-BGH is less than 0.1 I.U. per mg. 
It was thought possible that carboxymethyl-BGH 
might inhibit the action of BGH. However, when 40 
gg of this derivative was administered with 5 pg of BGH 
(Assay II) the growth promoting activity was slightly 
greater than that of 5 pg of BGH given alone (though 
the difference was not significant). Clearly, there is no 
evidence here for inhibition. 
3.2. 14C-labelled carboxymethyl-BGH and the reactivity 
of methionine residues 
Four major peptides located by autoradiography were 
eluted from peptide maps of material labelled in both 
the presence and the absence of urea. The location of 
these peptides in the amino acid sequence (determined 
from the amino acid composition and confirmed in 
some cases by sequence studies) is indicated in fig. 1. 
None of these peptides contained more than one 
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Table 2 
Reactivity of the methionine residues of 
bovine growth hormone. 
Specific activity of carboxymetjryl-Met 
residue* 
Residue 
(see fig. 1) No denaturant 8 M urea 
Met 1 
Met II 
Met III 
Met IV 
2,910 3,370 
1,030 1,400 
5,920 5,250 
4,550 5,090 
_ 
* Specific activities are expressed in dpm/nmole. BGH was re., 
acted with 14C-labelled iodoacetic acid in the presence or ab- 
sence of 8 M urea. 
methionine residue, so the specific activity of the car- 
boxymethyhnethionine could be readily determined 
from the amino acid composition data and the counts. 
These specific activities are shown in table 2. The spe- 
cific activities of the diiferent methionine residues 
gives a measure of their reactivity with iodoacetic acid. 
Clearly, in the absence of denaturant, there is a con- 
siderable difference between the reactivities of the 4 
methionine residues, residue II being markedly less re- 
active than any of the others. In the presence of 8 M 
urea, the differences are somewhat reduced, though 
they still remain. 
4. Discussion 
The amino acid sequences around methionine resi- 
dues I, III and IV (fig. 1) agree with those reported by 
other workers [l-3] . The sequence around methio- 
nine II differs somewhat from that of Santome et al. 
[3], though there is agreement hat there is a methio- 
nine residue in this region. Further studies on the ami- 
no acid sequence of BGH will be reported in detail 
elsewhere. 
The growth promoting activity of BGH in which all 
the methionine residues have been carboxymethylated 
is very low (table 1). This may be because at least one 
of the 4 methionine residues is required for biological 
activity, but such a conclusion must clearly be tentative 
at this stage, since carboxymethylation of the hormone 
is likely to be accompanied by conformational changes 
which could themselves lead to inactivation. In this 
respect it is interesting that a peptide of 41 residues 
corresponding to part of the sequence of human growth 
hormone not containing methionine has been synthe- 
sized chemically, and shows some growth hormone- 
like activity [ 131. 
The data shown in table 2 does not give absolute 
values for the reactivities of the methionine groups 
in BGH, but does give some indication of their relative 
reactivities. Clearly, methionine residue II is less reac- 
tive towards iodoacetic acid than are the others, and 
the differences in reactivity are only slightly reduced 
when the carboxymethylation is performed in 8 M 
urea. Either the reactivity of the methionine residues 
is not dependant solely on differences due to the con- 
formation of the protein, or (as seems more likely) 
8 M urea does not cause complete unfolding of the 
BGH molecule. Attempts to repeat the experiment us- 
ing guanidinium chloride as the denaturing agent have 
been unsuccessful, because the degree of labelling in the 
presence of this reagent is much lower than in the ab- 
sence of a denaturant, or in the presence of 8 M urea. 
It seems possible anyway that the low activity of methi- 
onine II in BGH is due to its inaccessibility to the re- 
agent, presumably because it is buried within the 3- 
dimensional structure of the protein. It is interesting 
that if the amino acid sequences of bovine, porcine 
[ 141 and human [ 15, 161 growth hormones are com- 
pared, onlymethionine II (of the 4 methionines in 
BGH) is conserved in all 3 species. 
Acknowledgements 
I thank Mrs. J. Dew and Mr. D. Watson for skilled 
technical assistance, and the Medical Research Council 
for a research grant. 
References 
[ 1] R.E. Fellows and A.D. Rogol, J. Biol. Chem. 244 (1969) 
1567. 
[2] R.E. Fellows, A.D. Rogol and A. Mudge, Excerpta Med. 
Int. Cong. Ser. No. 236; Abstracts 2nd Int. Symp. Growth 
Hormone (197 1) p 3. 
[3] J.A. Santome, J.M. Dellacha, A.C. Paladini, C.E.M. Wolfen- 
stein, C. PeHa, E. Poskus, S.T. Duarat, M.J. Biscoglio, Z.M.M. 
de Sese and A.V.F. de Sangiiesa, FEBS Letters 16 (1971) 198. 
121 
Volume 21, number 2 FEBS LETTERS March 1972 
[4] M. Wallis, FEBS Letters 3 (1969) 118. 
[5] M. WaJlis, Biochem. J. 125 (1971) 54P. 
[6] H.G. Gundlach, S. Moore and W.H. Stein, J. Biol. Chem. 
234 (1959) 1761. 
[ 71 M. WalJis and H.B.F. Dixon, Biochem. J. 100 (1966) 593. 
[8] C.H.W. Hirs, J. Biol. Chem. 219 (1956) 611. 
[9] P.J. Vithayathil and F.M. Richards, J. Biol. Chem. 235 
(1960) 2343. 
[lo] P. F&tss-Beth, Acta Pharmacol. Toxicol. 3 (1947) Sup- 
plement 3. 
[ 111 M. Wallis, (1972) in preparation. 
[ 121 M. WaJlis, Biochim. Biophys. Acta 115 (1966) 423. 
[ 131 F. Chillemi and A. Pecile, Experientia 27 (1971) 385. 
[ 141 A.E. Wilhelmi and J.B. Mills, COB. Int. Centre Natl. Rech. 
Sci. Paris 177 (1969) 165. 
[ 151 C.H. Li and J.S. Dixon, Arch. Biochem. Biophys. 146 
(1971) 233. 
[ 161 H.D. Niall, Nature New Biology 230 (1971) 90. 
122 
